You are here :
Home
Healthcare Market Research Reports
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
 |
North American Pulmonary drug delivery devices Market The North American Pulmonary Drug Delivery devices Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $13.8 billion in 2013 and expected to be $24 billion by 2018, growing at a CAGR of 11.8%. The Pulmonary Drug Delivery devices Market analyzes the market by segments such as nebulizers, dry powder inhalers (DPIs), and metered dose inhalers (MDIs).The prominent players in the Market are GlaxoSmithKline Pharmaceuticals Limited (GSK), Boehringer Ingelheim GmbH, and Astra Zeneca. |
Upcoming |
|
|
European Pulmonary drug delivery devices Market The European Pulmonary Drug Delivery devices devices Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $7.5 billion in 2013 and expected to be $12.4billion by 2018, growing at a CAGR of 10.6%. The Pulmonary Drug Delivery devices Market analyzes the market by segments such as nebulizers, dry powder inhalers (DPIs), and metered dose inhalers (MDIs).The prominent players in the Market are GlaxoSmithKline Pharmaceuticals Limited (GSK), Boehringer Ingelheim GmbH, and Astra Zeneca. |
Upcoming |
|
|
Asian Pulmonary Drug Delivery devices Market The Asian Pulmonary Drug Delivery devices Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $3.6 billion in 2013 and expected to be $7.7 billion by 2018, growing at a CAGR of 16.2%. The Pulmonary Drug Delivery devices Market analyzes the market by segments such as nebulizers, dry powder inhalers (DPIs), and metered dose inhalers (MDIs).The prominent players in the Market are GlaxoSmithKline Pharmaceuticals Limited (GSK), Boehringer Ingelheim GmbH, and Astra Zeneca. |
Upcoming |
|
|
North American Radiology PACS Market The North American radiology PACS market was valued at $898.8 million in 2013, and is expected to grow at a CAGR of 3.1% from 2014 to 2019. This market is segmented on the basis of geography, application, deployment, and end-user. Deep dive analysis of the top market players have also been considered in this report. |
Upcoming |
|
|
European Radiology PACS The European radiology picture archiving and communication system (PACS) market was valued at $513.6million in 2013, and is expected to grow at a CAGR of 4.3% from 2014 to 2019. This market is segmented on the basis of geography, application, deployment, and end-user. Deep dive analysis of the top market players have also been considered in this report. |
Upcoming |
|
|
Asian Radiology PACS Market The Asian radiology picture archiving and communication system (PACS) market was valued at $275.4 million in 2013, which is expected to grow at a CAGR of 5.5% from 2014 to 2019. This market has been segmented on the basis of geography, application, deployment, and end-user. A DeepDive analysis of the top market players has also been considered in this report. |
Upcoming |
|
|
North American Active Transdermal Drug Delivery Devices Market The North American Active Transdermal Drug Delivery Devices Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs, huge investment made by big pharmaceutical companies.The Market was Valued at $712 million in 2013 and expected to be $1339 million by 2018, growing at a CAGR of 13.5 %. The Transdermal Drug Delivery Devices Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven. |
Upcoming |
|
|
Enterprise Picture Archiving and Communication System (PACS) The global enterprise picture archiving and communication system (PACS) market was valued at $300.0 million in 2013, and is expected to grow at a CAGR of 10.4% from 2014-2019.. This market is segmented on the basis of geography, application, deployment, and end-user. Deep dive analysis of the top market players have also been considered in this report. |
Upcoming |
|
|
European Active Transdermal Drug Delivery Devices Market The European Active Transdermal Drug Delivery Devices Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs, huge investment made by big pharmaceutical companies.The Market was Valued at $353 million in 2013 and expected to be $633 million by 2018, growing at a CAGR of 12.4 %. The Transdermal Drug Delivery Devices Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven. |
Upcoming |
|
|
Asian Active Transdermal Drug Delivery Devices Market The Asian Active Transdermal Drug Delivery Devices Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs, huge investment made by big pharmaceutical companies.The Market was Valued at $109 million in 2013 and expected to be $188 million by 2018, growing at a CAGR of 11.6 %. The Transdermal Drug Delivery Devices Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven. |
Upcoming |
|
|
North American Enterprise Picture Archiving and Communication System (PACS) The market for enterprise PACS in North America is segmented on the basis of types, deployment, component, key applications, end-users, and geography. The market is estimated to witness a CAGR of 9.5% between 2014 and 2019. |
Upcoming |
|
|
European Enterprise Picture Archiving and Communication System (PACS) The market segmentation in this report is done in various segments, such as on the basis of types, deployment, component, key applications and end-users, and by geography (major countries of the region). The European Enterprise PACS Market is estimated to register a CAGR of 10.8% between 2014 and 2019. |
Upcoming |
|
|
Asian Enterprise Picture Archiving and Communication System (PACS) The Asian Enterprise Picture Archiving and Communication System (PACS) market was valued at $40 million in 2012, and is projected to reach $78 million by 2018, at a CAGR of 12.0%. This market is segmented on the basis of geography, application, deployment, and end-users. Deep dive analysis of the key market players, along with recent financials, product portfolio, and growth strategies are also considered in this report. |
Upcoming |
|
|
North American Passive Transdermal Drug Delivery Market The North American Passive Transdermal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs, huge investment made by big pharmaceutical companies.The Market was Valued at $6.85 billion in 2013 and expected to be $11.33 billion by 2018, growing at a CAGR of 10.6 %. The Transdermal Drug Delivery Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven. |
Upcoming |
|
|
European Passive Transdermal Drug Delivery Market The European Passive Transdermal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs, huge investment made by big pharmaceutical companies.The Market was Valued at $3.27 billion in 2013 and expected to be $5.19 billion by 2018, growing at a CAGR of 9.6 %. The Transdermal Drug Delivery Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven. |
Upcoming |
|
|
Asian Passive Transdermal Drug Delivery Market The Asian Passive Transdermal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs, huge investment made by big pharmaceutical companies.The Market was Valued at $1.40 billion in 2013 and expected to be $2.82 billion by 2018, growing at a CAGR of 15.0%. The Transdermal Drug Delivery Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven. |
Upcoming |
|
|
Asian Sutures Market The Asian Sutures Market was valued at $145 million in 2013 and estimated to be $169 million by 2018, at a CAGR of 3.2%. Sutures in terms of types are divided into absorbable and non-absorbable sutures and on the basis of materials are divided into natural and synthetic sutures. The key players of the market covered in this report are Smith & Nephew, 3M healthcare, Johnson and Johnson, Derma Sciences, Covidien and Molnlycke healthcare. |
Upcoming |
|
|
European Sutures Market The European Sutures Market was valued at $233 million in 2013 and estimated to be $246 million by 2018, at a CAGR of 1.30%. Sutures in terms of types are divided into absorbable and non-absorbable sutures and on the basis of materials are divided into natural and synthetic sutures. The key players of the market covered in this report are Johnson and Johnson, Derma Sciences, Covidien, Molnlycke healthcare, Smith & Nephew, 3M healthcare and others. |
Upcoming |
|
|
North American Sutures Market The North American Sutures Market was valued at $705 million in 2013 and estimated to be $763 million by 2018, at a CAGR of 1.80%. Sutures in terms of types are divided into absorbable and non-absorbable sutures and on the basis of materials are divided into natural and synthetic sutures. The key players of the market covered in this report are 3M healthcare, Johnson and Johnson, Derma Sciences, Covidien and Molnlycke healthcare, Smith & Nephew and others. |
Upcoming |
|
|
North America Wrist Replacement Devices Market The report “North American Wrist Replacement Devices Market forecast, 2012-2018 “analyzes the market of devices by 2 segments such as Total Wrist Implant and Total Wrist Fusion Devices. Both these segments experienced a positive growth till 2012 with an increased awareness for procedures and sophisticated diagnostic techniques. Both the markets have been witnessing the maximum growth because of increase in patient pool and procedure numbers of Wrist osteoarthritis and rheumatoid arthritis. |
Upcoming |
Healthcare
